Cargando…

Osteoprotegerin (OPG) Upregulation Activates Breast Stromal Fibroblasts and Enhances Their Pro-Carcinogenic Effects through the STAT3/IL-6 Signaling

Breast carcinomas are composed of cancer cells surrounded by various types of non-cancer cells such as fibroblasts. While active cancer-associated fibroblasts (CAFs) support tumor initiation and progression, quiescent breast stromal fibroblasts (BSFs) inhibit these effects through various cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Nasrallah, Huda K., Al-Ansari, Mysoon M., Aboussekhra, Abdelilah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655455/ https://www.ncbi.nlm.nih.gov/pubmed/36359766 http://dx.doi.org/10.3390/cells11213369

Ejemplares similares

ATR suppresses the pro-tumorigenic functions of breast stromal fibroblasts
por: Al-Ansari, Mysoon M., et al.
Publicado: (2018)

miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts
por: Al-Ansari, Mysoon M., et al.
Publicado: (2015)

Ionizing radiation normalizes the features of active breast cancer stromal fibroblasts and suppresses their paracrine pro-carcinogenic effects
por: Aboussekhra, Abdelilah, et al.
Publicado: (2023)

Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic
por: Al-Rakan, Maha A, et al.
Publicado: (2013)

The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts
por: Hendrayani, Siti-Fauziah, et al.
Publicado: (2016)

Caffeine Mediates Sustained Inactivation of Breast Cancer-Associated Myofibroblasts via Up-Regulation of Tumor Suppressor Genes
por: Al-Ansari, Mysoon M., et al.
Publicado: (2014)

CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6
por: Al-Rakan, Maha A., et al.
Publicado: (2016)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients
por: Al-Ansari, Mysoon M., et al.
Publicado: (2020)

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
por: Bjerre, Mette
Publicado: (2013)

The DNA methyl-transferase protein DNMT1 enhances tumor-promoting properties of breast stromal fibroblasts
por: Al-Kharashi, Layla A., et al.
Publicado: (2017)

Activated breast stromal fibroblasts exhibit myoepithelial and mammary stem cells features
por: Aboussekhra, Abdelilah, et al.
Publicado: (2023)

Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease
por: Bolon, B, et al.
Publicado: (2001)

Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression
por: Al-Harbi, Bothina, et al.
Publicado: (2018)

High DNMT1 Expression in Stromal Fibroblasts Promotes Angiogenesis and Unfavorable Outcome in Locally Advanced Breast Cancer Patients
por: Al-Kharashi, Layla A., et al.
Publicado: (2022)

p16(INK4A) Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
por: Al-Ansari, M M, et al.
Publicado: (2013)

p16(INK4A) Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
por: Al-Ansari, M M, et al.
Publicado: (2013)

p16(INK4A) Positively Regulates p21(WAF1) Expression by suppressing AUF1-dependent mRNA decay
por: Al-Khalaf, Huda H., et al.
Publicado: (2013)

AUF1 positively controls angiogenesis through mRNA stabilization-dependent up-regulation of HIF-1α and VEGF-A in human osteosarcoma
por: Al-Khalaf, Huda H., et al.
Publicado: (2019)

High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients
por: Al-Tweigeri, Taher, et al.
Publicado: (2022)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
por: Wang, Yan, et al.
Publicado: (2011)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
por: Eid, Riham, et al.
Publicado: (2023)

Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-Implantitis Susceptibility in a Chinese Han Population
por: Zhou, Jian, et al.
Publicado: (2016)

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021)

IL-1 but not IL-18 induces osteoprotegerin and TRAIL in rheumatoid arthritis synovial fibroblasts
por: Morel, J, et al.
Publicado: (2003)

The Impact of Angiotensin Converting Enzyme-2 (ACE-2) on Bone Remodeling Marker Osteoprotegerin (OPG) in Post-COVID-19 Iraqi Patients
por: AL-Azzawi, Islam S, et al.
Publicado: (2022)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
por: Reid, Penny E, et al.
Publicado: (2009)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
por: Hou, Lele, et al.
Publicado: (2011)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
por: Tariq, Saba, et al.
Publicado: (2022)

Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts
por: Zhang, L., et al.
Publicado: (2016)

The p16(INK4a) tumor suppressor controls p21(WAF1) induction in response to ultraviolet light
por: Al-Mohanna, Mai A., et al.
Publicado: (2007)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
por: Widschwendter, Martin, et al.
Publicado: (2015)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system
por: Skarlis, Charalampos, et al.
Publicado: (2018)

OPG rs2073617 polymorphism is associated with upregulated OPG protein expression and an increased risk of intervertebral disc degeneration
por: Xue, Jing-Bo, et al.
Publicado: (2016)

The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis
por: Peng, Yuqin, et al.
Publicado: (2018)

Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis
por: Goswami, Sudeshna, et al.
Publicado: (2016)

AUF1 promotes stemness in human mammary epithelial cells through stabilization of the EMT transcription factors TWIST1 and SNAIL1
por: AlAhmari, Manar M., et al.
Publicado: (2020)

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
por: Lane, Denis, et al.
Publicado: (2013)

The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis: Erratum
Publicado: (2019)

Osteoprotegerin (OPG) Promotes Recruitment of Endothelial Progenitor Cells (EPCs) via CXCR4 Signaling Pathway to Improve Bone Defect Repair
por: Zhang, Rongfeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0i6v1ppo9g2jk69ms49mtr1tb1